Cargando…
CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV
Hepatitis B remains a major global public health challenge, with particularly high prevalence in medically disadvantaged western Pacific and African regions. Although clinically available technologies for the qPCR detection of HBV are well established, research on point-of-care testing has not progr...
Autores principales: | Ding, Ronghua, Long, Jinzhao, Yuan, Mingzhu, Zheng, Xue, Shen, Yue, Jin, Yuefei, Yang, Haiyan, Li, Hao, Chen, Shuaiyin, Duan, Guangcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125043/ https://www.ncbi.nlm.nih.gov/pubmed/34063629 http://dx.doi.org/10.3390/ijms22094842 |
Ejemplares similares
-
CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
por: Ding, Ronghua, et al.
Publicado: (2021) -
The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases
por: Lou, Juan, et al.
Publicado: (2022) -
Application of CRISPR/Cas Systems in the Nucleic Acid Detection of Infectious Diseases
por: Li, Junwei, et al.
Publicado: (2022) -
Large-Scale Phylogenetic Analysis Reveals a New Genetic Clade among Escherichia coli O26 Strains
por: Long, Jinzhao, et al.
Publicado: (2022) -
Commentary: Study the Features of 57 Confirmed CRISPR Loci in 38 Strains of Staphylococcus aureus
por: Mao, Tingting, et al.
Publicado: (2019)